Feedback / Questions
AK002 - Allakos
http://www.globenewswire.com/news-release/2019/05/07/1818785/0/en/Allakos-Announces-Positive-Results-with-AK002-in-Patients-with-Severe-Allergic-Conjunctivitis.html
May 7, 2019
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next